Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Pharmagreen Biotech Inc (OP: PHBI )

0.0008 +0.0001 (+14.29%)
Streaming Delayed Price Updated: 9:30 AM EDT, Apr 24, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 10,000
Open 0.0008
Bid (Size) N/A (0)
Ask (Size) N/A (0)
Prev. Close 0.0007
Today's Range 0.0008 - 0.0008
52wk Range 0.0002 - 0.0059
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
PHBI - Pharmagreen Signs Supply Contract and Trade Marked Name Use of SierraSil(R) in Its’ Nutraceutical Formulations
Via ACCESSWIRE
PHBI Pharmagreen Starts Sales of MaxGenomicTM Supplement on Amazon.com and Develops Its Next Pre-Workout Formulation
Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations. 
Via NewMediaWire

Performance

YTD
+33.33%
+33.33%
1 Month
+14.29%
+14.29%
3 Month
-11.11%
-11.11%
6 Month
+33.33%
+33.33%
1 Year
-80.95%
-80.95%

More News

Read More
PHBI Pharmgreen Launches Online Sales for Its MaxGenomic Supplement Product
Via NewMediaWire
Pharmagreen Appoints Tyrell Crosby, a Professional Athlete, as Its Honorary Sports Ambassador
Via NewMediaWire
PHBI Pharmagreen Biotech Appoints Ethan Styles as Vice President of Product Research and Development
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
PHBI Pharmagreen Develops a Proprietary Nutraceutical Formulation and Prepares for Product Launch
Via NewMediaWire
PHBI - Pharmagreen Provides Updates On Its Business Developments Beyond Just Cannabis
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Pharmagreen Biotech (OTCQB: PHBI): Breaking Down the Catalysts for Future Growth
Via Spotlight Growth
Topics Cannabis
Exposures Cannabis
PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
PHBI - Pharmagreen Biotech Provides Updates on Its Ongoing Business Developments
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
PHBI Pharmagreen Announces Another Milestone Completed Towards the Acquisition of Long Valley Farms LLC.
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
PHBI Pharmagreen Announces Affirmed MOU To Acquire Licensed California Cannabis Company
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
PHBI - Pharmagreen Biotech Announces Up-Listing To OTCQB Venture Market
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Pharmagreen Taps Revenue Potential of Proprietary Cannabis Tissue Culture Technology Asset
Via NewMediaWire
Topics Cannabis Intellectual Property
Exposures Cannabis Intellectual Property
PAO Group, Inc. Expands Development Deal With Puration To Pursue Tissue Culture Technology (OTC Pink: PAOG)
Via AB Newswire
Topics Cannabis
Exposures Cannabis
Pharmagreen Prepares for Entry Into the Multi-Billion Dollar California Cannabis Industry
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Analyst Lowers Price Targets On These Leading Stocks; $TLRY Enters Spirits Market – Cannabis Daily, November 4, 2021
Via Benzinga
Topics Cannabis
Exposures Cannabis
Pharmagreen Submits Its Application for Uplisting to the OTCQB Venture Market
Via NewMediaWire
Topics Cannabis
Exposures Cannabis
Pharmagreen Provides Update on Funding and Acquisition Progress
Via NewMediaWire
Topics Cannabis Regulatory Compliance
Exposures Cannabis Legal Regulatory
Pharmagreen Signs MOU to Acquire a California Based Cannabis Company
Via NewMediaWire
Topics Cannabis Economy
Exposures Cannabis Economy
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.